These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3484967)

  • 1. An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma.
    Miller GJ; Seghatchian MJ; Walter SJ; Howarth DJ; Thompson SG; Esnouf MP; Meade TW
    Br J Haematol; 1986 Feb; 62(2):379-84. PubMed ID: 3484967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII.
    Muller AD; van Deijk WA; Devilée PP; van Dam-Mieras MC; Hemker HC
    Br J Haematol; 1986 Feb; 62(2):367-77. PubMed ID: 3484966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of factors XII and VII induced in citrated plasma in the presence of contact surface.
    Mitropoulos KA; Martin JC; Stirling Y; Morrisey JH; Cooper JA
    Thromb Res; 1995 Apr; 78(1):67-75. PubMed ID: 7778067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial triglycerides and blood coagulation.
    Silveira A
    Exp Clin Endocrinol Diabetes; 2001; 109(4):S527-32. PubMed ID: 11453040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype.
    Irish AB; Green FR
    Nephrol Dial Transplant; 1998 Mar; 13(3):679-84. PubMed ID: 9550647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human factor VII during clotting in vitro.
    Rao LV; Bajaj SP; Rapaport SI
    Blood; 1985 Jan; 65(1):218-26. PubMed ID: 3871163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that factor VII levels correlate strongly with fibrinopeptide A release: evaluation by an ex vivo method.
    Mariani G; Iacopino G; Pasquali-Lasagni R
    Int J Clin Lab Res; 1992; 22(2):111-4. PubMed ID: 1504303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface.
    Mitropoulos KA; Reeves BE; O'Brien DP; Cooper JA; Martin JC
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):223-34. PubMed ID: 8499561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease.
    Miller GJ; Walter SJ; Stirling Y; Thompson SG; Esnouf MP; Meade TW
    Br J Haematol; 1985 Feb; 59(2):249-58. PubMed ID: 3871629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in factor VII activation in healthy women.
    Scarabin PY; Van Dreden P; Bonithon-Kop C; Orssaud G; Bara L; Conard J; Samama M
    Clin Sci (Lond); 1988 Oct; 75(4):341-3. PubMed ID: 3264227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII.
    Seligsohn U; Osterud B; Rapaport SI
    Blood; 1978 Nov; 52(5):978-88. PubMed ID: 698402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to measure factor VII and factor VII activation.
    Osterud B
    Haemostasis; 1983; 13(3):161-8. PubMed ID: 6350121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
    Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
    Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Evidence for increased conversion of VII to alpha VIIa and higher flux within the coagulation pathway.
    Mitropoulos KA; Esnouf MP; Meade TW
    Atherosclerosis; 1987 Jan; 63(1):43-52. PubMed ID: 3493783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
    Peverill RE; Teede HJ; Smolich JJ; Malan E; Kotsopoulos D; Tipping PG; McGrath BP
    Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa.
    Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR
    Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.
    Mitropoulos KA; Miller GJ; Reeves BE; Wilkes HC; Cruickshank JK
    Atherosclerosis; 1989 Apr; 76(2-3):203-8. PubMed ID: 2730717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in factor VII proteolysis in vivo.
    Ofosu FA; Craven S; Dewar L; Anvari N; Andrew M; Blajchman MA
    Br J Haematol; 1996 Aug; 94(2):407-12. PubMed ID: 8759906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
    Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
    Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel.
    Mazzeffi M; Szlam F; Jakubowski JA; Tanaka KA; Sugidachi A; Levy JH
    Thromb Res; 2013 Jul; 132(1):106-11. PubMed ID: 23664633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.